Zosano Pharma Corporation ZSANQ OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score

27/100

1/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Zosano Pharma Corporation (ZSANQ) .

Criteria proven by this page:

VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 25/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score

27/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

HEALTH

50/100

Debt-to-Equity & liquidity

→ Health

✗

MOAT

0/100

→ Income

✓

GROWTH

73/100

→ Income

✗

INCOME

10/100

→ Income

Valuation Snapshot — ZSANQ

Valuation Multiples

P/E (TTM)0.0

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.00

P/S Ratio0.03

EV/EBITDA0.0

Per Share Data

EPS (TTM)$-0.27

Book Value / Share$0.00

Revenue / Share$0.01

FCF / Share$0.00

Yields & Fair Value

Earnings YieldN/A

Dividend Yield0.00%

EPS: Actual vs Estimates

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2012	$6.98	$11.62M	$1.82M	15.6%
2013	$-21.52	$4.25M	$-5.61M	-132%
2014	$-24.52	$2.86M	$-14.24M	-497.8%
2015	$-49.81	$313K	$-28.43M	-9082.1%
2016	$-43.32	$0.00	$-29.83M	-
2017	$-16.82	$0.00	$-29.11M	-
2018	$-3.74	$0.00	$-35.36M	-
2019	$-2.29	$0.00	$-37.59M	-
2020	$-0.49	$224K	$-33.37M	-14896.9%
2021	$-0.27	$785K	$-30.11M	-3836.2%